Eversept Partners
Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NTRA, GSK, TEVA, UTHR, HZNP, and represent 39.88% of Eversept Partners's stock portfolio.
- Added to shares of these 10 stocks: INSP (+$27M), HCA (+$16M), TECH (+$13M), KRYS (+$13M), AMRN (+$13M), ABCM (+$12M), TEVA (+$11M), RGEN (+$8.5M), IFRX (+$8.5M), UTHR (+$8.5M).
- Started 18 new stock positions in KURA, KRYS, CVAC, FGEN, BDTX, WAT, SPRY, AMRN, URGN, Fibrogen. STRO, ABCM, INSP, ELV, APLS, PTGX, MOH, IFRX.
- Reduced shares in these 10 stocks: , HZNP (-$35M), GSK (-$31M), Amarin Corp Plc option (-$22M), NTRA (-$20M), Amedisys Inc. Cmn Stk cmn (-$17M), AVTR (-$15M), BCRX (-$15M), ITCI (-$12M), GH (-$11M).
- Sold out of its positions in Amarin Corp Plc option, Amedisys Inc. Cmn Stk cmn, Anthem Inc opt, AVTR, BIIB, GH, Heska Corporation, ITCI, THC.
- Eversept Partners was a net seller of stock by $-148M.
- Eversept Partners has $966M in assets under management (AUM), dropping by -15.71%.
- Central Index Key (CIK): 0001697013
Tip: Access up to 7 years of quarterly data
Positions held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Eversept Partners
Eversept Partners holds 71 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Natera (NTRA) | 12.2 | $118M | -14% | 2.4M | 48.66 |
|
GSK Sponsored Adr (GSK) | 10.7 | $104M | -22% | 2.9M | 36.02 |
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 6.0 | $58M | +23% | 7.7M | 7.53 |
|
United Therapeutics Corporation (UTHR) | 5.9 | $58M | +17% | 260k | 220.75 |
|
Horizon Therapeutics Pub L SHS (HZNP) | 5.1 | $49M | -41% | 475k | 102.85 |
|
Syndax Pharmaceuticals (SNDX) | 4.7 | $46M | 2.2M | 20.93 |
|
|
Community Health Systems (CYH) | 3.3 | $32M | -19% | 7.3M | 4.40 |
|
Bio-techne Corporation (TECH) | 2.9 | $28M | +81% | 343k | 81.63 |
|
Vera Therapeutics Cl A (VERA) | 2.9 | $28M | -2% | 1.7M | 16.05 |
|
Inspire Med Sys (INSP) | 2.8 | $27M | NEW | 82k | 324.64 |
|
Celldex Therapeutics Com New (CLDX) | 2.8 | $27M | +13% | 786k | 33.93 |
|
Danaher Corporation (DHR) | 2.6 | $25M | -30% | 103k | 240.27 |
|
Hca Holdings (HCA) | 2.5 | $25M | +189% | 81k | 303.48 |
|
Illumina (ILMN) | 2.4 | $23M | -27% | 124k | 187.49 |
|
Icon SHS (ICLR) | 1.9 | $18M | -6% | 72k | 250.20 |
|
BioCryst Pharmaceuticals (BCRX) | 1.7 | $17M | -47% | 2.4M | 7.04 |
|
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.7 | $16M | 5.3M | 3.10 |
|
|
Catalent (CTLT) | 1.6 | $16M | -37% | 357k | 43.36 |
|
Seres Therapeutics (MCRB) | 1.5 | $15M | +21% | 3.1M | 4.79 |
|
Krystal Biotech (KRYS) | 1.3 | $13M | NEW | 107k | 117.40 |
|
Amarin Corp Spons Adr New (AMRN) | 1.3 | $13M | NEW | 11M | 1.19 |
|
Abcam Ads (ABCM) | 1.3 | $12M | NEW | 499k | 24.47 |
|
Invesco Qqq Tr Put | 1.1 | $10M | -22% | 3.5k | 2968.56 |
|
Centene Corporation (CNC) | 1.1 | $10M | -47% | 153k | 67.45 |
|
Ionis Pharmaceuticals (IONS) | 1.0 | $9.9M | -20% | 242k | 41.03 |
|
Vaxcyte (PCVX) | 1.0 | $9.8M | -34% | 196k | 49.94 |
|
Taro Pharmaceutical Inds SHS (TARO) | 1.0 | $9.5M | +2% | 250k | 37.93 |
|
Repligen Corporation (RGEN) | 1.0 | $9.3M | +1068% | 66k | 141.46 |
|
Inflarx Nv (IFRX) | 0.9 | $8.5M | NEW | 1.9M | 4.46 |
|
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.9 | $8.2M | +1409% | 692k | 11.89 |
|
Model N (MODN) | 0.8 | $7.9M | -7% | 223k | 35.36 |
|
Spdr S&p 500 Etf Tr Put | 0.8 | $7.5M | -43% | 2.3k | 3273.12 |
|
Liquidia Corporation Com New (LQDA) | 0.8 | $7.3M | +27% | 925k | 7.85 |
|
Xenon Pharmaceuticals (XENE) | 0.7 | $6.6M | -15% | 171k | 38.50 |
|
Molina Healthcare (MOH) | 0.7 | $6.4M | NEW | 21k | 301.24 |
|
Puma Biotechnology (PBYI) | 0.6 | $5.9M | -14% | 1.7M | 3.53 |
|
Shockwave Med (SWAV) | 0.6 | $5.7M | -57% | 20k | 285.41 |
|
Humana (HUM) | 0.6 | $5.3M | -47% | 12k | 448.00 |
|
Pennant Group (PNTG) | 0.5 | $5.3M | +2% | 432k | 12.28 |
|
Apellis Pharmaceuticals (APLS) | 0.5 | $5.1M | NEW | 56k | 91.10 |
|
Kura Oncology (KURA) | 0.5 | $4.8M | NEW | 451k | 10.58 |
|
Iqvia Holdings (IQV) | 0.4 | $4.2M | +30% | 19k | 224.77 |
|
eHealth (EHTH) | 0.4 | $4.0M | -59% | 503k | 8.04 |
|
Medpace Hldgs (MEDP) | 0.4 | $3.7M | +33% | 16k | 240.17 |
|
Curevac N V (CVAC) | 0.4 | $3.7M | NEW | 357k | 10.42 |
|
Sutro Biopharma (STRO) | 0.4 | $3.5M | NEW | 748k | 4.65 |
|
Merus N V (MRUS) | 0.4 | $3.5M | 131k | 26.33 |
|
|
Agilent Technologies Inc C ommon (A) | 0.4 | $3.4M | +117% | 29k | 120.47 |
|
Protagonist Therapeutics (PTGX) | 0.3 | $3.2M | NEW | 115k | 27.62 |
|
Biohaven (BHVN) | 0.3 | $3.1M | -29% | 131k | 23.92 |
|
Paratek Pharmaceuticals (PRTK) | 0.3 | $2.9M | +107% | 1.3M | 2.21 |
|
Waters Corporation (WAT) | 0.3 | $2.9M | NEW | 11k | 266.54 |
|
PerkinElmer (RVTY) | 0.3 | $2.5M | +72% | 21k | 118.79 |
|
Black Diamond Therapeutics (BDTX) | 0.2 | $2.2M | NEW | 427k | 5.05 |
|
Gohealth Cl A New (GOCO) | 0.2 | $2.1M | -16% | 105k | 19.71 |
|
Xoma Corp Del Com New (XOMA) | 0.2 | $1.7M | 90k | 18.89 |
|
|
Evolus (EOLS) | 0.2 | $1.7M | +3% | 229k | 7.27 |
|
Argenx Se Sponsored Adr (ARGX) | 0.2 | $1.6M | +8% | 4.2k | 389.73 |
|
Zai Lab Adr (ZLAB) | 0.2 | $1.5M | -67% | 55k | 27.73 |
|
Spdr Ser Tr Put | 0.1 | $1.1M | +12% | 900.00 | 1228.96 |
|
Anthem (ELV) | 0.1 | $1.0M | NEW | 2.3k | 444.29 |
|
Affimed Therapeutics B V (AFMD) | 0.1 | $1.0M | -10% | 1.7M | 0.60 |
|
Gossamer Bio (GOSS) | 0.1 | $900k | -44% | 750k | 1.20 |
|
Aerovate Therapeutics (AVTE) | 0.1 | $862k | 50k | 17.15 |
|
|
Urogen Pharma (URGN) | 0.1 | $774k | NEW | 75k | 10.35 |
|
Aadi Bioscience (AADI) | 0.1 | $697k | 102k | 6.84 |
|
|
Ac Immune Sa SHS (ACIU) | 0.0 | $368k | 125k | 2.96 |
|
|
Silverback Therapeutics (SPRY) | 0.0 | $327k | NEW | 49k | 6.70 |
|
Amn Healthcare Svcs Put | 0.0 | $134k | +137% | 950.00 | 141.12 |
|
Fibrogen Put | 0.0 | $87k | NEW | 388.00 | 223.52 |
|
Fibrogen (FGEN) | 0.0 | $15k | NEW | 5.6k | 2.70 |
|
Past Filings by Eversept Partners
SEC 13F filings are viewable for Eversept Partners going back to 2017
- Eversept Partners 2023 Q2 filed Aug. 14, 2023
- Eversept Partners 2023 Q1 filed May 15, 2023
- Eversept Partners 2022 Q4 filed Feb. 14, 2023
- Eversept Partners 2022 Q3 filed Nov. 14, 2022
- Eversept Partners 2022 Q2 filed Aug. 15, 2022
- Eversept Partners 2022 Q1 filed May 16, 2022
- Eversept Partners 2021 Q4 filed Feb. 14, 2022
- Eversept Partners 2021 Q3 filed Nov. 15, 2021
- Eversept Partners 2021 Q2 filed Aug. 16, 2021
- Eversept Partners 2021 Q1 filed May 13, 2021
- Eversept Partners 2020 Q4 filed Feb. 16, 2021
- Eversept Partners 2020 Q3 restated filed Nov. 13, 2020
- Eversept Partners 2020 Q3 filed Nov. 12, 2020
- Eversept Partners 2020 Q2 filed Aug. 13, 2020
- Eversept Partners 2020 Q1 filed May 13, 2020
- Eversept Partners 2019 Q4 filed Feb. 13, 2020